Indian Finnish (Europe)
  Lean Obese Obese Healthy Controls
BMI 15.6 ± 1.5 28.4 ± 2.8 29.0 ± 4.1 26.7 ± 2.6
FBG (mMol/ L) 17.9 ± 4.2* 8.6 ± 1.4 7.9 ±1.7 -
A) Serum ALT (IU/L) 33.6 ± 16.9 32.4 ± 21.3 - -
x) MEGX (IU/L) 43.5 ± 18.1 45.4 ± 30.4 57.9 ±35.9 35.9 ± 11.0
y) Antipyrine; t1/2 8.2 ± 3.5** 14.2 ± 0.9 17.5 ± 4.3 11.1 ± 6.1
Test of significance: * = P<0.05 , ** = P<0.01
Table 7: Results of Antipyrine clearance and Lidocaine metabolic (MEGX) conversion study in Indian and Finnish Type 2 DM patients [14].